We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2025
Programme
Head & neck
02 May 2025 - 06 May 2025
Vienna, Austria
ESTRO 2025
Session
Head & neck
Session Type:
Digital Poster
Track:
Clinical
Journey:
Add to
My Programme
Is Gemzar-cisplatin induction chemotherapy less effective than triplet induction chemotherapy in locally advanced nasopharyngeal carcinoma?
Presenter
:
Nejla Fourati
,
Tunisia
Presentation Number:
E25-662
Frequency and Trends of Re-planning During Adjuvant Radiation Therapy in Oral Cavity Cancer Patients with Flap Reconstruction: A Prospective Analysis
Presenter
:
Laraib Khan
,
Pakistan
Presentation Number:
E25-3693
Radiological Depth of invasion as a surrogate for need of nodal dissection in oral cavity cancers: A retrospective anlaysis.
Presenter
:
Pragyat Thakur
,
India
Presentation Number:
E25-3703
Comparison between T1-, T2- and T1 StarVibe-weighted MRI and contrast-enhanced CT based delineation of organs at risk in head and neck radiotherapy
Presenter
:
Adelina Brezae
,
Romania
Presentation Number:
E25-3761
Quality of life and financial toxicity in head and neck cancer patients treated with particle therapy: a prospective study (NCT05947149)
Presenter
:
Rossana Ingargiola
,
Italy
Presentation Number:
E25-3788
Surgery versus radiotherapy in T2N0 laryngeal cancer: A unicentric retrospective study
Presenter
:
Nicolas DENY
,
France
Presentation Number:
E25-3929
Outcomes in anaplastic thyroid carcinoma after spatially fractionated radiotherapy
Presenter
:
Elizabeth McKone
,
USA
Presentation Number:
E25-3988
Evaluation of a deep-learning based auto-segmentation tool for organs at risk in extensively preoperated head and neck cancer patients
Presenter
:
Norina Predescu
,
Romania
Presentation Number:
E25-4004
Management of head and neck squamous cell carcinoma with N3 nodal disease
Presenter
:
Lei Wang
,
United Kingdom
Presentation Number:
E25-769
Prognostic factors and outcomes in oral cavity cancer patients:
Presenter
:
Jesus Romero Fernandez
,
Spain
Presentation Number:
E25-4020
treatment outcomes of intra-arterial chemoradiotherapy for locally advanced tongue cancer
Presenter
:
Yutaka Toyomasu
,
Japan
Presentation Number:
E25-4047
Outcome Prediction Before Definitive Chemoradiation in Older Adults With Head-and-Neck Cancer Using Artificial Neural Networks
Presenter
:
Sebastian Norbert Marschner
,
Germany
Presentation Number:
E25-4086
The value of re-resection to achieve R0 status in HNSCC patients undergoing adjuvant chemoradiation – preliminary results of a monocenter study
Presenter
:
Erik Haehl
,
Germany
Presentation Number:
E25-4106
Impact of sarcopenia on acute toxicity for head and neck cancer patients treated with hadrontherapy: a prospective study (NCT06207708)
Presenter
:
Rossana Ingargiola
,
Italy
Presentation Number:
E25-4136
Benchmarking Multi-Specialty Interobserver Performance in Radiographic Detection and Staging of Mandibular Osteoradionecrosis Using the ClinRad System
Presenter
:
Zeph Kaffey
,
USA
Presentation Number:
E25-4195
Outcomes of proton therapy in the treatment of sinonasal cancers: a single-center experience.
Presenter
:
Rossana Ingargiola
,
Italy
Presentation Number:
E25-4230
Financial toxicity in Romanian head and neck cancer patients – a cross-sectional study
Presenter
:
Renata Zahu
,
Romania
Presentation Number:
E25-4241
Definitive hypofractionated radiotherapy of head and neck squamous cell carcinoma (HNSCC) in frail and elderly patients
Presenter
:
Petra Štefková
,
Slovakia
Presentation Number:
E25-805
The bacterial composition of Head and Neck tumours can resolve hypoxia/immune gene expression-based prognosis in patients with mixed patterns
Presenter
:
Jacopo Iacovacci
,
Italy
Presentation Number:
E25-4247
incidence of nodal involvement of IX level in Head & Neck cancer: a multicenter retrospective analysis.
Presenter
:
Fabrizio Sanna
,
Italy
Presentation Number:
E25-4261
Psychological Impact of Radiodermatitis After Radiotherapy for Head and Neck Cancer: A 5-Year Retrospective Study
Presenter
:
FATIMA ZAHRA CHRAA
,
Morocco
Presentation Number:
E25-4331
Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy
Presenter
:
Laura Montezuma
,
Spain
Presentation Number:
E25-4340
Investigation of a novel methodology to select patients for PTV margin reduction via daily adaptive radiotherapy for head and neck cancer
Presenter
:
Andrew Mcpartlin
,
Canada
Presentation Number:
E25-4365
Impact of active smoking on early survival and acute severe toxicities of patients treated with radiotherapy for head and neck cancer.
Presenter
:
Louis Munschi
,
France
Presentation Number:
E25-4367
GLIM-based Malnutrition Prevalence in Head and Neck Cancer Patients Undergoing Treatment: A Prospective Study
Presenter
:
Mariangela Massaccesi
,
Italy
Presentation Number:
E25-4396
Efficacy of an epigallocatechin gallate mouthwash in the prevention of radiation-induced mucositis in locally advanced head and neck cancer
Presenter
:
BIANCA SANTO
,
Italy
Presentation Number:
E25-4403
influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis
Presenter
:
Scarlet Marie Crespo Perez
,
Spain
Presentation Number:
E25-4419
Mucosa sparing strategy in Head and neck cancers treated with hypofractionated carbon-ion therapy
Presenter
:
Ankita Nachankar
,
Austria
Presentation Number:
E25-870
Long-term Outcomes of Salivary Gland Cancer: A Five-Year Analysis of Survival and Disease Control from a Single Center
Presenter
:
Carmen Hernandez-Carrillo Martínez-Almeida
,
Spain
Presentation Number:
E25-4421
Squamous cell carcinoma of nasal vestibule: the prognostic role of the four staging system classifications
Presenter
:
Stefano Durante
,
Italy
Presentation Number:
E25-4493
Clinical outcomes and QOL in 39 patients with head and neck mucosal melanoma after hypofractionated spot scanning proton therapy: retrospective study
Presenter
:
Koichiro Nakajima
,
Japan
Presentation Number:
E25-903
A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure outcomes in head and neck squamous cell carcinoma
Presenter
:
Morten Horsholt Kristensen
,
Denmark
Presentation Number:
E25-923
Acute kidney injury following radical chemo-radiotherapy for head and neck cancer: a review of practice at a tertiary oncology centre
Presenter
:
Leah Brooks
,
United Kingdom
Presentation Number:
E25-937
Pretreatment APOE levels and survival in nasopharyngeal carcinoma: A retrospective analysis.
Presenter
:
Xianming He
,
China
Presentation Number:
E25-986
Low-dose Fractionated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Controlled Trial?NCT05292027?
Presenter
:
Mei Feng
,
China
Presentation Number:
E25-232
Base of tongue volume and dose as predictors of late dysphagia in oral cavity cancer patients treated with IMRT: a retrospective analysis.
Presenter
:
Joseph Azria
,
France
Presentation Number:
E25-1011
Stereotactic radiotherapy for cT1-2 glottic larynx cancer on MR-Linac: preliminary results of a treatment planning study
Presenter
:
Sabine Linden
,
The Netherlands
Presentation Number:
E25-1082
Dose-Response Characteristics and Predictive Study of Radiation Dermatitis in the Neck Region during Nasopharyngeal Cancer Radiotherapy
Presenter
:
Haiyan Peng
,
China
Presentation Number:
E25-1106
Machine Learning Prediction of Secondary Recurrence in Head and Neck Cancer after Reirradiation Using a Weighted Average Model on Pre-reRT PET Imaging
Presenter
:
Arnaud Beddok
,
France
Presentation Number:
E25-1238
Evaluating Quad Shot Radiotherapy for Locally Advanced Head and Neck Cancer: A Multicenter Analysis of Factors Influencing Survival
Presenter
:
Jordan Stanton
,
United Kingdom
Presentation Number:
E25-1272
Conventional Fractionation vs. Stereotactic Body Radiotherapy: A Comparative Approach in Postoperative Management of Head and Neck Sarcomas
Presenter
:
Alper Kahvecioglu
,
Turkey
Presentation Number:
E25-1308
Tubarial gland sparing for oropharyngeal cancer: Feasibility with Intensity Modulated Proton Therapy & Intensity Modulated Radiation Therapy
Presenter
:
Omer Gal
,
USA
Presentation Number:
E25-245
Navigating neurocognition; feasibility of online neurocognitive assessment in survivors of oropharyngeal cancer
Presenter
:
Zsuzsanna Iyizoba-Ebozue
,
United Kingdom
Presentation Number:
E25-1373
Exploring Gender-Specific Nutritional Disparities in Head and Neck Cancer Patients Treated with (Chemo)Radiotherapy
Presenter
:
Anastassia Löser
,
Germany
Presentation Number:
E25-1383
Selection strategy for adaptive radiotherapy in patients with nasopharyngeal cancer: a single institution experience
Presenter
:
Sandra Nuyts
,
Belgium
Presentation Number:
E25-1485
Implementation of Spatially Fractionated Radiotherapy (SFRT) in Palliative Treatment of Advanced Head and Neck Cancers
Presenter
:
Tomasz Winiecki
,
Poland
Presentation Number:
E25-1515
Comparative Dosimetric Analysis of Radiotherapy Techniques for Early Vocal Cord Carcinoma: A Single-Center Experience
Presenter
:
Frandeina Pinto Guevara
,
Spain
Presentation Number:
E25-1588
Geriatric head and neck squamous cell carcinomas (GHNC) treated with modulated radiotherapy (MRT): Preliminary single Institution outcome.
Presenter
:
Jay Prakash Sahu
,
India
Presentation Number:
E25-1619
Long-term treatment outcomes of patients with oral tongue squamous cell carcinoma in a multidisciplinary tertiary care setting.
Presenter
:
Nwaf Alkhanein
,
Saudi Arabia
Presentation Number:
E25-1626
Fear of cancer recurrence in adults with HPV-positive oropharyngeal cancer after (chemo)radiation – A bicentric cross-sectional observational study
Presenter
:
Alexander Rühle
,
Germany
Presentation Number:
E25-1633
Dosimetric trismus predictors in HNC: interim analysis of a prospective international study
Presenter
:
Orges Spahiu
,
Albania
Presentation Number:
E25-1636
Cephalometric findings predict trismus in HNC patients: interim analysis of a prospective international study
Presenter
:
Orges Spahiu
,
Albania
Presentation Number:
E25-1643
Hyperfractionated chemoradiotherapy in locally-advanced unresectable head and neck squamous cell carcinoma: a prospective study
Presenter
:
Reza Ghalehtaki
,
Germany
Presentation Number:
E25-1790
Photobiomodulation in head and neck cancer patients undergoing chemoradiotherapy: role in toxicities prevention, update data
Presenter
:
Margherita Rotondi
,
Italy
Presentation Number:
E25-1866
A single institution study on patterns of relapse and survival outcomes in head and neck salivary gland carcinomas treated with surgery and IMRT
Presenter
:
Justin Kar Wai Ng
,
China, Hong Kong Special Administrative Region
Presentation Number:
E25-1879
Efficacy of immunotherapy in Epstein-Barr Virus-Negative Recurrent/Metastatic Nasopharyngeal Carcinoma: A Study from Non-High-Incidence Areas
Presenter
:
Lei Wang
,
China
Presentation Number:
E25-1973
Safe variation from the “5+5” expansion rule for the delineation of primary tumor clinical target volume (CTV-P) in oropharyngeal cancer
Presenter
:
Carlotta Becherini
,
Italy
Presentation Number:
E25-1991
A prospective study about oral nutrition supplement in local advanced nasopharyngeal carcinoma patients: an update of long-term survival
Presenter
:
Yuan-yuan Chen
,
China
Presentation Number:
E25-2011
The utility of F-18 FDG PET-CT imaging in the work-up and management of salivary gland malignancies
Presenter
:
Yashna Nadkarni
,
United Kingdom
Presentation Number:
E25-2045
Olfactory function in nasopharyngeal carcinoma patients after radiotherapy: a preliminary report of a prospective cohort study.
Presenter
:
Kansiree Benjangkhaprasert
,
Thailand
Presentation Number:
E25-2100
Value of diffusion-weighted MRI for persistent skull base invasion of nasopharyngeal cancer after radiotherapy
Presenter
:
Sergi Benavente
,
Spain
Presentation Number:
E25-2133
The effect of evolving clinical practice in head and neck radiotherapy: auto-planning and new CTV guidelines
Presenter
:
Eva Onjukka
,
Sweden
Presentation Number:
E25-2285
The impact of haemoglobin and package time on head and neck squamous cell cancer outcomes after radical surgery and adjuvant radiotherapy
Presenter
:
Lei Wang
,
United Kingdom
Presentation Number:
E25-2310
Characterization of distant metastases in salivary gland cancer patients undergoing upfront surgery followed by postoperative radiation therapy
Presenter
:
Dong Soo Lee
,
Korea Republic of
Presentation Number:
E25-2311
Effects of scheduled replanning during dose painting on organs at risk for head and neck squamous cell carcinoma
Presenter
:
Anneliz de Leeuw
,
The Netherlands
Presentation Number:
E25-2329
PATTERNS OF FAILURE IN PORT IN ADENOID CYSTIC CARCINOMA: 13 YEARS EXPERIENCE
Presenter
:
Pablo Araguas Mora
,
Spain
Presentation Number:
E25-2331
Evaluation of Submandibular Gland Function Using Quantitative Pertechnetate Scintigraphy in Submandibular-Sparing Radiation for Head and Neck Cancers
Presenter
:
Prasoon Garg
,
India
Presentation Number:
E25-454
Selective mucosal and nodal irradiation in patients of head and neck carcinoma of unknown primary (HNCUP): Emergence of primary, outcome and toxicity.
Presenter
:
Monali Swain
,
India
Presentation Number:
E25-2453
Bayesian analysis of dose to the medulla oblongata and dysphagia One-Year after head and neck radiotherapy
Presenter
:
Golnoosh Motamedi-Ghahfarokhi
,
United Kingdom
Presentation Number:
E25-2482
The morphological and dosimetric changes of target volumes and organs at risk during radiotherapy for nasopharyngeal carcinoma
Presenter
:
Guanqun Zhou
,
China
Presentation Number:
E25-2526
Acute Toxicity Comparison Between IMPT and VMAT for Nasopharyngeal Cancer: A Propensity Score-Matched Analysis
Presenter
:
Kiattisa Sommat
,
Singapore
Presentation Number:
E25-2646
Recurrence Patterns After Definitive Radiotherapy for SCC Locally Advanced Pharyngeal and Laryngeal: Real-World Insights in the Modern Era!
Presenter
:
Linda Agolli
,
Germany
Presentation Number:
E25-2665
Curative proton reirradiation (re-PT) in recurrent head and neck cancers (HNC): outcomes and toxicities
Presenter
:
Seedarat Suwichanarakul
,
Thailand
Presentation Number:
E25-457
Radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on MR-linac: preliminary outcomes and comparison with helical tomotherapy
Presenter
:
Andrea Guerini
,
Italy
Presentation Number:
E25-2747
Cross-Sectional Sternocleidomastoid Muscle Area in MRI as a Marker for Sarcopenia and Survival Outcomes in Nasopharyngeal Cancer Patients
Presenter
:
JENG-YOU WU
,
Taiwan, Province of China
Presentation Number:
E25-2749
Feasibility of reduced margin daily online adaptive radiotherapy(DART) in head and neck cancer-interim technical analysis of ongoing prospective study
Presenter
:
HARJOT KAUR BAJWA
,
India
Presentation Number:
E25-2770
Fighting xerostomia in head and neck patients treated with radiotherapy: the challenging strategy of the parotid gland stem cell sparing.
Presenter
:
Daniela Alterio
,
Italy
Presentation Number:
E25-2790
Do pretreatment CT and PET radiomics predict individual lymph node failure after (chemo)radiotherapy in head and neck cancer patients?
Presenter
:
Nanna Sijtsema
,
The Netherlands
Presentation Number:
E25-2791
Prognostication with lymphocyte counts and their kinetics during chemoradiotherapy for HPV-positive oropharyngeal carcinoma
Presenter
:
Andrew Mcpartlin
,
Canada
Presentation Number:
E25-2792
Survival outcomes of HPV-negative Head and Neck cancer patients treated by definitive radiotherapy or radiochemotherapy: data from three centers.
Presenter
:
Marek Slavik
,
Czech Republic
Presentation Number:
E25-2907
Contrastive Learning Guided by Clinical Risk Scores Enhances WSI-Based Progression-Free Survival Prediction in Head and Neck Cancer
Presenter
:
Shirin A. Enger
,
Canada
Presentation Number:
E25-2983
EORTC 2014-HNCG PROLoNg: Pembrolizumab and Radiotherapy for OLigometastatic squamous cell carcinoma of the head and Neck, randomized phase III trial
Presenter
:
Panagiotis Balermpas
,
Switzerland
Presentation Number:
E25-3002
Identifying modifiable patient and treatment characteristics in long-term PEG-dependent head and neck cancer patients
Presenter
:
Saeed Salman
,
Canada
Presentation Number:
E25-3018
Adjuvant radiotherapy for pleomorphic dermal sarcoma of the head and neck
Presenter
:
Matthew Fahy
,
Ireland
Presentation Number:
E25-3069
Stereotactic boost radiotherapy to head and neck cancer patients: single institution experience
Presenter
:
Vitali Moiseenko
,
USA
Presentation Number:
E25-3120
Outcomes of Palliative Hypofractionated Radiotherapy with 50 Gy in 20 fractions with or without a treatment Break in Head and Neck Cancer Patients
Presenter
:
AARTHI IYER
,
Canada
Presentation Number:
E25-3172
Regional recurrence rates in clinically node negative sinonasal cancers without elective neck treatment
Presenter
:
osagie igiebor
,
USA
Presentation Number:
E25-3178
Automated imaging-based tumor burden predicts pre-treatment circulating tumor DNA in HPV-associated oropharynx cancers
Presenter
:
Mina Bakhtiar
,
USA
Presentation Number:
E25-3181
Influence of testosterone supplementation on HPV-positive oropharyngeal squamous cell carcinoma outcomes after radiotherapy
Presenter
:
Andres Frias
,
USA
Presentation Number:
E25-3218
Quality of life and return to work after radiotherapy in young adults with head-and-neck cancer – A bicentric cross-sectional observational study
Presenter
:
Alexander Rühle
,
Germany
Presentation Number:
E25-588
Research on the application of Raman spectroscopy in predicting the efficacy of nasopharyngeal carcinoma treatment and assessing adverse reactions
Presenter
:
peng zhang
,
China
Presentation Number:
E25-3234
Integrating Dosimetric and Tooth Avulsion Status for Personalized Risk Prediction of Mandibular Osteoradionecrosis in Head and Neck Cancer
Presenter
:
Ahmed Allam Mohamed
,
Germany
Presentation Number:
E25-3402
Zinc Gluconate Oral Spray for Preventing Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy: Preliminary Results from a RCT.
Presenter
:
Mariangela Massaccesi
,
Italy
Presentation Number:
E25-3491
ITHACA-ORION: Tools for Head and Neck Cancer – Early Post-Operative NI-RADS to Predict Recurrence in High-Risk Oral Cancer.
Presenter
:
Mariangela Massaccesi
,
Italy
Presentation Number:
E25-3522
prospective clinical validation of a fully automated decision making system for adaptive radiotherapy in nasopharyngeal carcinoma
Presenter
:
Guanqun Zhou
,
China
Presentation Number:
E25-3532
Efficacy of administering pentoxifylline, tocopherol, with or without clodronate, to irradiated head and neck cancer patients with osteoradionecrosis
Presenter
:
Dustin Jan Cruz
,
Philippines
Presentation Number:
E25-3583
Tumor asphericity a novel FDG-PET parameter for risk stratification head and neck squamous cell carcinoma
Presenter
:
Patrick Hausmann
,
Germany
Presentation Number:
E25-3599
Early Results Of RadiomicART Trial: A Prospective Monocenter Study Of Multi-Imaging Adaptive Radiotherapy For Locally Advanced Head-Neck Cancer
Presenter
:
Mariya Boyanova Ilieva
,
Italy
Presentation Number:
E25-3691
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.